CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Andreas Meyer-Lindenberg

OPENALEX: A5006015276↗ORCID: 0000-0001-5619-1123↗

Affiliations

Organizations

Central Institute of Mental Healthauthorship · DE Heidelberg Universityauthorship · DE University Hospital Heidelbergauthorship · DE

Public evidence

3 connected articles

Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.2024 · Europe PMC [Differential diagnostic distinction between substance-induced and primary psychoses: : Recommendations for general psychiatric and forensic practice].2021 · PubMed Central Open Access Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling.2016 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Andreas Meyer-Lindenberg - Medical Cannabis Research Engine